The efficacy and safety of osimertinib in treating nonsmall cell lung cancer: A PRISMA-compliant systematic review and meta-analysis

BACKGROUND: Epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) is the primary treatment in treating with EGFR mutant nonsmall cell lung cancer (NSCLC). This systematic review and meta-analysis aimed to evaluate the efficacy and safety of the third-generation EGFR-TKI, osimertinib,...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Medicine (Baltimore)
Main Authors: Liu, Jing, Li, Xuemei, Shao, Yinghong, Guo, Xiyun, He, Jinggui
Format: Artigo
Sprog:Inglês
Udgivet: Lippincott Williams & Wilkins 2020
Fag:
6700
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7447427/
https://ncbi.nlm.nih.gov/pubmed/32846826
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000021826
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker